Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

被引：0
|
作者：
Rivera-Caravaca, J. M. [1 ]
Esteve-Pastor, M. A. [1 ]
Vicente, V. [2 ]
Valdes, M. [1 ]
Lip, G. Y. [3 ]
Marin, F. [1 ]
Roldan-Schilling, V. [2 ]
机构：
[1] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[2] Univ Murcia, Hosp Univ Morales Meseguer, Murcia, Spain
[3] Birmingham City Hosp, Birmingham, W Midlands, England
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6442
引用
收藏
页码：1347 / 1348
页数：2
相关论文
共 50 条
  • [41] Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation
    Waldo, Albert L.
    CARDIOLOGY CLINICS, 2009, 27 (01) : 125 - +
  • [42] Anticoagulation: Stroke prevention in patients with atrial fibrillation
    Waldo, Albert L.
    MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 (01) : 143 - +
  • [43] Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project
    Philippart, Raphael
    Brunet-Bernard, Anne
    Clementy, Nicolas
    Bourguignon, Thierry
    Mirza, Alain
    Angoulvant, Denis
    Babuty, Dominique
    Lip, Gregory Y. H.
    Fauchier, Laurent
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 1056 - 1063
  • [44] Atrial Fibrillation Is an Independent Risk Factor of Poor Stroke Outcome and Mortality in Chinese Ischaemic Stroke Patients
    Li, R.
    Cheng, S.
    Mok, M.
    Yeung, E.
    Lee, C. N.
    Auyeung, M.
    Cheung, C. M.
    Tsoi, T. H.
    CEREBROVASCULAR DISEASES, 2013, 36 : 74 - 74
  • [45] Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Alan S. Go
    Guy L. Reed
    Elaine M. Hylek
    Kathleen A. Phillips
    MS Lin Liu
    Lori E. Henault
    Joe V. Selby
    Daniel E. Singer
    Journal of Thrombosis and Thrombolysis, 2003, 15 : 41 - 46
  • [46] Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Liu, L
    Henault, LE
    Selby, JV
    Singer, DE
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 15 (01) : 41 - 46
  • [47] Factor v leiden mutation and risk of stroke in atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Chang, Y
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 530 - 530
  • [48] The Long-Term Impact of Ischemic Stroke on Mortality Among Patients with Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Fang, Margaret C.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Singer, Daniel E.
    STROKE, 2011, 42 (03) : E80 - E81
  • [49] Oral Anticoagulation in elderly Patients with Atrial Fibrillation
    Hupfer, M.
    Gosch, M.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 : S125 - S125
  • [50] Utility of current stroke risk schemes in patients with atrial fibrillation: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Go, AS
    Chang, YC
    Henault, LE
    Jensvold, NJ
    Singer, DE
    CIRCULATION, 2006, 113 (08) : E302 - E302
12345